
Inovio Pharmaceuticals Prices $20 Million Public Offering
Inovio Pharmaceuticals is raising $20 million through a public offering of common stock and warrants, the company announced Tuesday. The Plymouth Meeting-based biotech firm, which specializes in DNA medicines for HPV-related diseases and cancer, finalized the deal at a combined price of $0.95 per share and warrant.






















